Hyperglycemia induced by clozapine and its alternative therapy: a case report

doi:10.3868/j.issn.2096-0689.2022.02.004

Journal of Translational Neuroscience

2022, Vol. 7

Issue (2) : 18-21 https://doi.org/10.3868/j.issn.2096-0689.2022.02.004

Case Report

Hyperglycemia induced by clozapine and its alternative therapy: a case report

Lan Jiang, Yuhang Liang, Tiankai Jiang, Yanjun Wang^*

Department of Integrated Chinese and Western Medicine, The Affiliated Mental Hospital of Kunming Medical University, Kunming 650000, China

Download: PDF(4316 KB)
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Abstract Clozapine has been recognized as the best drug for the treatment of refractory schizophrenia, but its clinical use is very cautious. Clozapine has many side effects, among which agranulocytosis is fatal. And it often causes glucose intolerance, leading to type 2 diabetes. The treatment plan for elevated blood glucose in clozapine patients is still unclear. This paper will report one case of glucose intolerance caused by clozapine and its alternative treatment, and discuss the treatment plan.

Keywords schizophrenia clozapine glucose intolerance alternative therapy

Issue Date: 25 June 2022

Cite this article:

Lan Jiang, Yuhang Liang, Tiankai Jiang, Yanjun Wang. Hyperglycemia induced by clozapine and its alternative therapy: a case report[J]. Journal of Translational Neuroscience,2022, 7(2): 18-21.

URL:

https://academic.hep.com.cn/jtn/EN/10.3868/j.issn.2096-0689.2022.02.004
https://academic.hep.com.cn/jtn/EN/Y2022/V7/I2/18

[1]	Zhilan Yang, Hongying Pan, Lan Jiang, Yuhang Liang, Jie Wu. Research progress of the synapsin 2 gene polymorphism in the pathogenesis of schizophrenia[J]. Journal of Translational Neuroscience, 2022, 7(1): 1-5.
[2]	Zhilan Yang, Hongying Pan, Lan Jiang, Tiankai Jiang, Yinhang Li, Jie Wu. Research progress on the mechanism of N6-methyladenosine methylation modification and proteolipid protein 1 gene in schizophrenia[J]. Journal of Translational Neuroscience, 2022, 7(1): 6-10.
[3]	Zhilan Yang, Hongying Pan, Lan Jiang, Tiantian Jiang, Jie Wu. Research progress of hsa-miR-495-3p and proteolipid protein 1 involvement in the pathogenesis of schizophrenia[J]. Journal of Translational Neuroscience, 2022, 7(1): 11-14.
[4]	Yanbing Xiong, Xianbin Li, Zhen Mao, Lei Zhao, Yilang Tang, Chuanyue Wang. Prepulse inhibition deficits in antipsychotic-naïve first-episode schizophrenia: a meta-analysis[J]. Journal of Translational Neuroscience, 2018, 3(2): 23-34.
[5]	Zhemeng Wu, Qian Wang. Cognitive deficits in schizophrenia: from pharmacology to neurocognitive models[J]. Journal of Translational Neuroscience, 2018, 3(1): 1-11.
[6]	Anthony J Hannan. Optimising validity and translational potential in rodent models of brain disorders[J]. Journal of Translational Neuroscience, 2016, 1(2): 56-62.
[7]	Rena Li, Xin Ma, Gang Wang, Jian Yang, Chuanyue Wang. Why sex differences in schizophrenia?[J]. Journal of Translational Neuroscience, 2016, 1(1): 37-42.

Viewed

Full text

Abstract

Cited

Shared

Discussed